HomeTRINITYTRINITY Opens First European Office in Munich

TRINITY Opens First European Office in Munich

TRINITY, a strategic partner to leading life sciences companies, today officially opened its flagship European office in Munich, Germany. The 20-year-old firm, with over 250 professionals working with more than 100 biopharmaceutical and medical device clients annually, will now serve clients from a dedicated European office.

“We are very excited to open this new chapter for TRINITY, and we look forward to serving our European clients directly from our European office,” said David Fitzhenry, TRINITY CEO.

Alexander Fink
Alexander Fink

Alexander Fink, Managing Partner Europe, will head TRINITY’s operations in Europe and will oversee strategy and direction in the European markets.

 

Jackson Carroll
Jackson Carroll

Jackson Carroll, Principal, joins his leadership team and will be supported by a team combining European experience both at TRINITY and from other top-tier strategic advisory firms. The European team will be positioned to develop evidence-based solutions for life sciences companies in Europe, leveraging European experience and seamlessly integrating TRINITY’s global knowledge and tools.

“We are pleased to be joining TRINITY, a firm that puts client needs first and brings deep biopharmaceutical experience across our three pillars: advisory services, insights & analytics, and technology,” said Fink.

Over the course of his 20-plus years in management consulting, Fink has advised more than 70 clients in over 300 strategic assignments. He joins from Syneos Health, where he built the European commercial strategy consulting business, and recently headed the global Product & Franchise Strategy service line as Senior Managing Director. Prior to Syneos Health, Fink spent a number of years in senior positions in top-tier consulting firms, such as Oliver Wyman and Monitor. Fink studied business administration in Germany, UK and the US.

Jackson Carroll brings over 17 years of experience in management consulting to TRINITY. He also joins from Syneos Health where he was a Senior Engagement Manager in its Commercial Advisory Group. Prior to that Carroll worked at global strategy consulting firms ZS Associates and McKinsey & Company. He earned an MBA with distinction from London Business School.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy